The Norwegian royal palace confirmed today that Crown Princess Mette-Marit, 49, has been placed on the national waiting list for a lung transplant. The announcement follows a prolonged period of ill health attributed to idiopathic pulmonary fibrosis, a chronic lung disease for which she has been receiving treatment since 2018.
Palace officials stated that the crown princess’s condition has deteriorated to the point where a transplant is now considered the only viable medical option. She remains under the care of specialists at Oslo University Hospital, where her status is classified as urgent.
The decision to go public, palace sources said, was made to pre-empt speculation and to provide the Norwegian public with a clear account of her medical situation. “Her Royal Highness is in a stable condition given the circumstances, and she is receiving the best possible medical care,” the statement read. “The waiting period for a suitable donor organ is unknown.”
Crown Princess Mette-Marit, married to Crown Prince Haakon, the heir to the Norwegian throne, has gradually reduced her public engagements over the past year. Her illness first came to light in 2018 when she stepped back from several royal duties. In recent months, she has appeared at only a handful of official events, notably the National Day celebrations in May.
Medical experts note that idiopathic pulmonary fibrosis causes progressive scarring of the lung tissue, leading to severe breathlessness and reduced oxygen exchange. A lung transplant is the only treatment that can significantly extend life expectancy, though it carries substantial risks including rejection and infection.
Norway’s organ donation system operates on a national priority list, with patients assessed according to clinical urgency and compatibility. The average wait time for a lung transplant in Norway is between six months and two years, though urgent cases may be expedited if a matching donor becomes available.
The crown princess’s plight has drawn attention to the broader issue of organ donation in Scandinavia. Norway has one of the highest rates of organ donation in Europe, but demand still outstrips supply. The palace has not made an appeal for donors, respecting the privacy of the royal family and the medical protocols involved.
Political reactions were measured. Prime Minister Jonas Gahr Støre offered his best wishes on behalf of the government, while opposition leader Erna Solberg echoed those sentiments. The royal household has asked for privacy during this period, and no further updates are expected until a transplant is either performed or the situation changes.
For the Norwegian monarchy, the health crisis unfolds at a delicate moment. Crown Prince Haakon, who has assumed additional duties, is widely seen as a steady successor to his father, King Harald V. The king, now 87, has himself faced repeated health issues, including hospitalisation for an infection earlier this year.
The palace confirmed that all of the crown princess’s official engagements have been cancelled until further notice. Her children, including stepson Marius Borg Høiby and the two younger children with the crown prince, have been informed and are receiving family support.
The case is a stark reminder of the vulnerability even within the most protected of institutions. For now, Norway waits with the crown princess for a donor that may or may not arrive in time.
